Capsule for treating cardiovascular and cerebrovascular diseases, and making method thereof

A technology for cardiovascular and cerebrovascular diseases and a production method, which is applied in cardiovascular system diseases, blood diseases, capsule delivery, etc., to achieve the effects of removing cardiovascular and cerebrovascular stasis deposits, improving cardio-cerebral hypoxia, and low cost

Inactive Publication Date: 2017-04-26
喻鸿章
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The nitrates, calcium antagonists, receptor blockers and antiplatelet drugs for the treatment of coronary heart disease, angina pectoris and myocardial infarction on the market have great side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The present invention is further set forth below in conjunction with embodiment. In the following detailed description, certain exemplary embodiments of the invention are described by way of illustration only. Needless to say, those skilled in the art would realize that the described embodiments can be modified in various different ways, all without departing from the spirit and scope of the present invention. Accordingly, the description is illustrative in nature and not intended to limit the scope of the claims.

[0031] A capsule for treating cardiovascular and cerebrovascular diseases, comprising the following components in proportions by weight:

[0032] Main ingredients: Ginseng 5-15, Panax notoginseng 5-20, Saffron 5-15, Sika antler 5-12, Diao Hailong 5-12, Pangolin 5-15, Chuan Fritillaria 5-12, Agarwood 3-10, Musk 1~5;

[0033] Excipients: Caulis Spatholobus 1.5~2.5, Purple Salvia 1.5~2.5, Polygonum multiflorum 1.5~2.5, Wild Hawthorn 2.5~3.5, Ginkgo biloba 1....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a capsule for treating cardiovascular and cerebrovascular diseases. The capsule comprises main materials and auxiliary materials; the main materials comprise, by weight, 5-15 parts of ginseng, 5-20 parts of panax notoginseng, 5-15 parts of Crocus sativus, 5-12 parts of antler, 5-12 parts of Solenognathus hardwickii, 5-15 parts of pangolins, 5-12 parts of Fritillaria cirrhosa, 3-10 parts of Chinese Eaglewood and 1-5 parts of musk; the auxiliary materials comprise, by weight, 1.5-2.5 parts of Caulis Spatholobi, 1.5-2.5 parts of Salvia miltiorrhiza, 1.5-2.5 parts of Polygonum multiflorum, 2.5-3.5 parts of wild hawthorn fruits, 1.5-2.5 parts of Folium Ginkgo, 0.5-1.5 parts of Ligusticum wallichii, 0.5-1.5 parts of radix paeoniae rubra, 0.5-1.5 parts of Rosewood Heart Wood, 0.5-1.5 parts of corydalis tuber, 0.5-1.5 parts of sappan wood, 0.5-1.5 parts of Acorus gramineus and 0.5-1.5 parts of lumbricus; and a weight ratio of the main materials to the auxiliary materials is 1:1 to 1:3. The invention also discloses a making method of the capsule. Above medicines have synergism, so the capsule rapidly removes blood stasis, improves heart and brain hypoxia, removes cardiovascular and cerebrovascular blood stasis deposition, and enlarges cardiovascular and cerebrovascular constriction parts. Compared with commercial medicines with the same effects, the capsule has the advantages of no side effects, treatment of both manifestation and root cause of diseases, and low cost.

Description

technical field [0001] The invention relates to a capsule for treating cardiovascular and cerebrovascular diseases, and also relates to a preparation method of the capsule for treating cardiovascular and cerebrovascular diseases. Background technique [0002] With the acceleration of people's life rhythm and the change of people's living environment, more and more people suffer from cardiovascular and cerebrovascular diseases. The occurrence and onset of cardiovascular and cerebrovascular stenosis are caused by various factors. Cerebrovascular diseases , is a chronic disease with high mortality and disability rates, which makes people suffer from great fear and pain. At present, no matter western medicine or traditional Chinese medicine, in the treatment of cardiovascular and cerebrovascular diseases, the effect of expanding the stenosis of cardiovascular and cerebrovascular diseases is not satisfactory. The nitrates, calcium antagonists, receptor blockers and antiplatelet ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8966A61K9/48A61P9/00A61P7/02A61P9/08A61K35/62A61K35/60A61K35/55A61K35/36A61K35/32
CPCA61K36/8966A61K9/4841A61K35/32A61K35/36A61K35/55A61K35/60A61K35/62A61K36/16A61K36/236A61K36/258A61K36/48A61K36/486A61K36/537A61K36/65A61K36/66A61K36/704A61K36/71A61K36/734A61K36/835A61K36/88A61K36/888A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 喻鸿章张坤岳
Owner 喻鸿章
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap